Ovid Therapeutics Inc.
OVID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26 | -$52 | -$54 | $120 |
| Dep. & Amort. | $1 | $2 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $7 | $7 | $0 |
| Change in WC | -$0 | $2 | -$8 | -$17 |
| Other Non-Cash | -$36 | -$5 | -$1 | $15 |
| Operating Cash Flow | -$56 | -$46 | -$55 | $119 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | -$10 | -$3 | $0 |
| Inv. Purchases | -$73 | -$112 | -$173 | -$2 |
| Inv. Sales/Matur. | $128 | $120 | $90 | $0 |
| Other Inv. Act. | -$0 | -$0 | -$1 | $0 |
| Investing Cash Flow | $55 | -$3 | -$88 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $30 | $0 | $0 |
| Stock Issued | $1 | $1 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$0 |
| Financing Cash Flow | $1 | $31 | $0 | $1 |
| Forex Effect | $0 | $0 | $0 | -$2 |
| Net Chg. in Cash | -$1 | -$18 | -$143 | $116 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29 | $47 | $190 | $72 |
| End Cash | $28 | $29 | $47 | $188 |
| Free Cash Flow | -$56 | -$46 | -$57 | $118 |